August 6, 2021

In follow up to a review of current indirect costs of industry sponsored clinical trials/research, the Office of Research in coordination with College of Medicine and Research Accounting Services has agreed upon a 35% rate for indirect costs for all industry sponsored clinical trials/research. This change is retroactively effective to April 1, 2021.

If you have any questions, please do not hesitate to contact ras@drexel.edu or Maria T. Schulthies, PhD or Aleister J. Saunders, PhD directly.